MoonLake Immunotherapeutics company logo
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$448.03M$62.98M-12.32%

Summary

Current Value
As of today, MLTX annual cash & cash equivalents is $448.03M, down -12.32% on
Historical Performance
MLTX annual cash & cash equivalents is up +5473.31% over the past 3 years, and up +33437.49% over the past 5 years
All-Time High Comparison
MLTX annual cash & cash equivalents is currently -12.32% below its historical high of $511.01M set on
3-Year Low Comparison
MLTX annual cash & cash equivalents is +521.27% above its 3-year low of $72.11M reached on an earlier date
Sector Comparison
MLTX annual cash & cash equivalents is higher than 88.03% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MLTX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$448.03M-12.3%+5473.3%+10000.0%+10000.0%
Quarterly Cash & Cash Equivalents$380.48M-23.0%+355.9%+100.0%+100.0%
Price$18.49-61.6%+52.9%+60.8%
Annual Current Assets$474.29M-7.8%+4821.7%+10000.0%+10000.0%
Annual Total Liabilities$24.54M+88.1%+15.1%+491.4%+491.4%
Annual Working Capital$451.82M-10.4%+4045.8%+10000.0%+10000.0%
Annual Net Income-$121.24M-175.1%-126.0%-10000.0%-10000.0%

Cash and Cash Equivalents Highs

MLTX Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$511.01M-12.3%
5Y$511.01M-12.3%
All$511.01M-12.3%

Cash and Cash Equivalents Lows

MLTX Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$72.11MN/A+521.3%
5Y$1.34MN/A>+9999.0%
All$1.34M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$448.03M-12.3%
$511.01M+608.6%
$72.11M+797.1%
YearValueChange
$8.04M+501.8%
$1.34M-

FAQ

  • What is the current annual cash & cash equivalents of MLTX?

    As of today, MLTX annual cash & cash equivalents is $448.03M

  • What is 1-year change in MLTX annual cash & cash equivalents?

    MLTX annual cash & cash equivalents is down -12.32% year-over-year

  • What is 3-year change in MLTX annual cash & cash equivalents?

    MLTX annual cash & cash equivalents is up +5473.31% over the past 3 years

  • How far is MLTX annual cash & cash equivalents from its all-time high?

    MLTX annual cash & cash equivalents is currently -12.32% below its historical high of $511.01M set on December 31, 2023

  • How does MLTX annual cash & cash equivalents rank versus sector peers?

    MLTX annual cash & cash equivalents is higher than 88.03% of companies in Healthcare sector

  • When is MLTX next annual earnings release?

    The next annual earnings release for MLTX is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. MLTX Official Website www.moonlaketx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1821586/000182158625000022/0001821586-25-000022-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821586/000182158625000006/0001821586-25-000006-index.htm
  4. MLTX Profile on Yahoo Finance finance.yahoo.com/quote/MLTX
  5. MLTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mltx